Systematic Review of Single-Agent vs. Multi-Agent Chemotherapy for Advanced Pancreatic Adenocarcinoma in Elderly vs. Younger Patients

SIMPLE SUMMARY: Pancreatic adenocarcinoma is an aggressive tumour with a high mortality, often diagnosed at advanced stages. The current standard of care for first-line therapy is multi-agent FOLFIRINOX or gemcitabine plus nab-Paclitaxel. Pancreatic adenocarcinoma predominantly effects the elderly p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Alison, Nagrial, Adnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136963/
https://www.ncbi.nlm.nih.gov/pubmed/37190218
http://dx.doi.org/10.3390/cancers15082289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136963/
https://www.ncbi.nlm.nih.gov/pubmed/37190218
http://dx.doi.org/10.3390/cancers15082289

Ejemplares similares